The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
NF-κB and cancer — identifying targets and mechanisms
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Self-citationTwist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Estimating the world cancer burden: Globocan 2000
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2001) · International Journal of Cancer · doi:10.1002/ijc.1440 · Cited by 3,721
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Self-citationActivators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
Suppression of TNF-α-Induced Apoptosis by NF-κB
Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
The two NF-κB activation pathways and their role in innate and adaptive immunity
Bonizzi, G., & Karin, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.03.008 · Cited by 2,535
Self-citationNF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
Self-citationIKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Self-citationNF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90807-x · Cited by 1,993
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955
Self-citationKamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Self-citationInhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
Maeda, S., Kamata, H., Luo, J.-L., Leffert, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,164
Self-citationHuber, M. A., Azoitei, N., Baumann, B., Grünert, S., Sommer, A., Pehamberger, H., Kraut, N., Beug, H., & Wirth, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421358 · Cited by 1,033
Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma
Keats, J. J., Fonseca, R., Chesi, M., Schop, R., Baker, A., Chng, W.-J., Van Wier, S., Tiedemann, R., Shi, C.-X., Sebag, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.003 · Cited by 983
IKK-γ is an essential regulatory subunit of the IκB kinase complex
Rothwarf, D. M., Zandi, E., Natoli, G., & Karin, M. (1998) · Nature · doi:10.1038/26261 · Cited by 957
Self-citationAnnunziata, C. M., Davis, R. E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F., Lenz, G., Hanamura, I., Wright, G., Xiao, W., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.004 · Cited by 952
Innate Immunity Gone Awry: Linking Microbial Infections to Chronic Inflammation and Cancer
Karin, M., Lawrence, T., & Nizet, V. (2006) · Cell · doi:10.1016/j.cell.2006.02.016 · Cited by 942
Self-citationCircuitry of nuclear factor κB signaling
Hoffmann, A., & Baltimore, D. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00375.x · Cited by 907
Cummins, E. P., Berra, E., Comerford, K. M., Ginouves, A., Fitzgerald, K. T., Seeballuck, F., Godson, C., Nielsen, J. E., Moynagh, P., Pouyssegur, J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602235103 · Cited by 788
Infections as a major preventable cause of human cancer
Kuper, H., Adami, H. ‐., & Trichopoulos, D. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00742.x · Cited by 740
TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling
Becker, C., Fantini, M. C., Schramm, C., Lehr, H. A., Wirtz, S., Nikolaev, A., Burg, J., Strand, S., Kiesslich, R., Huber, S., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.020 · Cited by 726
Chauhan, D., Catley, L., Li, G., Podar, K., Hideshima, T., Velankar, M., Mitsiades, C., Mitsiades, N., Yasui, H., Letai, A., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.013 · Cited by 694
Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression
Bassères, D. S., & Baldwin, A. S. (2006) · Oncogene · doi:10.1038/sj.onc.1209942 · Cited by 667
Luo, J.-L., Maeda, S., Hsu, L.-C., Yagita, H., & Karin, M. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.012 · Cited by 603
Self-citationDeletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma
Luedde, T., Beraza, N., Kotsikoris, V., van Loo, G., Nenci, A., De Vos, R., Roskams, T., Trautwein, C., & Pasparakis, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.016 · Cited by 597
Chua, H. L., Bhat-Nakshatri, P., Clare, S. E., Morimiya, A., Badve, S., & Nakshatri, H. (2007) · Oncogene · doi:10.1038/sj.onc.1209808 · Cited by 596
Regulation of Spontaneous Intestinal Tumorigenesis Through the Adaptor Protein MyD88
Rakoff-Nahoum, S., & Medzhitov, R. (2007) · Science · doi:10.1126/science.1140488 · Cited by 584
Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin
Luo, J.-L., Tan, W., Ricono, J. M., Korchynskyi, O., Zhang, M., Gonias, S. L., Cheresh, D. A., & Karin, M. (2007) · Nature · doi:10.1038/nature05656 · Cited by 436
Self-citationTh, M., van Nieuwkerk, C. M., Dingemans, K. P., Smit, J. J., Schinkel, A. H., Notenboom, R. G. E., Weerman, M. A. V. D. B., VERKRUISEN, R. P., Groen, A. K., & Elferink, R. P. J. O. (1994) · PubMed · Cited by 403
Sakurai, T., Maeda, S., Chang, L., & Karin, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603499103 · Cited by 400
Self-citationMakris, C., Godfrey, V. L., Krähn-Senftleben, G., Takahashi, T., Roberts, J. L., Schwarz, T., Feng, L., Johnson, R. S., & Karin, M. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80262-2 · Cited by 395
Self-citationTargeting the NF-κB signaling pathway in Notch1-induced T-cell leukemia
Vilimas, T., Mascarenhas, J., Palomero, T., Mandal, M., Buonamici, S., Meng, F., Thompson, B., Spaulding, C., Macaroun, S., Alegre, M.-L., et al. (2007) · Nature Medicine · doi:10.1038/nm1524 · Cited by 335
PIDD Mediates NF-κB Activation in Response to DNA Damage
Janssens, S., Tinel, A., Lippens, S., & Tschopp, J. (2005) · Cell · doi:10.1016/j.cell.2005.09.036 · Cited by 319
IKKβ Is Required for Prevention of Apoptosis Mediated by Cell-Bound but Not by Circulating TNFα
Maeda, S., Chang, L., Li, Z.-W., Luo, J.-L., Leffert, H., & Karin, M. (2003) · Immunity · doi:10.1016/s1074-7613(03)00301-7 · Cited by 286
Self-citationHorikawa, T., Yang, J., Kondo, S., Yoshizaki, T., Joab, I., Furukawa, M., & Pagano, J. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3933 · Cited by 211
Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2
Wang, X., Belguise, K., Kersual, N., Kirsch, K. H., Mineva, N. D., Galtier, F., Chalbos, D., & Sonenshein, G. E. (2007) · Nature Cell Biology · doi:10.1038/ncb1559 · Cited by 209
Rigby, R. J., Simmons, J. G., Greenhalgh, C. J., Alexander, W. S., & Lund, P. K. (2007) · Oncogene · doi:10.1038/sj.onc.1210286 · Cited by 154
Critical role for NF‐κB‐induced JunB in VEGF regulation and tumor angiogenesis
Schmidt, D., Textor, B., Pein, O. T., Licht, A. H., Andrecht, S., Sator‐Schmitt, M., Fusenig, N. E., Angel, P. E., & Schorpp‐Kistner, M. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601539 · Cited by 151
Cao, Y., Luo, J., & Karin, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706728104 · Cited by 149
Self-citationNuclear IKK activity leads to dysregulated Notch-dependent gene expression in colorectal cancer
Fernández‐Majada, V., Aguilera, C., Villanueva, A., Vilardell, F., Robert‐Moreno, A., Aytés, À., Real, F. X., Capellá, G., Mayo, M. W., Espinosa, L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606476104 · Cited by 145
Weichert, W., Boehm, M., Gekeler, V., Bahra, M., Langrehr, J. M., Neuhaus, P., Denkert, C., Imre, G., Weller, C., Hofmann, H.-P., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603878 · Cited by 143
Scartozzi, M., Bearzi, I., Pierantoni, C., Mandolesi, A., Loupakis, F., Zaniboni, A., Catalano, V., Quadri, A., Zorzi, F., Berardi, R., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.5022 · Cited by 136
The role of NF-κB-1 and NF-κB-2-mediated resistance to apoptosis in lymphomas
Bernal‐Mizrachi, L., Lovly, C. M., & Ratner, L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507809103 · Cited by 129
Zou, P., Kawada, J., Pesnicak, L., & Cohen, J. I. (2007) · Journal of Virology · doi:10.1128/jvi.02241-06 · Cited by 104
Fabre, C., Carvalho, G., Tasdemir, E., Braun, T., Adès, L., Grosjean, J., Boehrer, S., Métivier, D., Souquère, S., Pierron, G., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210187 · Cited by 96
Singh, S., Shi, Q., Bailey, S. T., Palczewski, M. J., Pardee, A. B., Iglehart, J. D., & Biswas, D. K. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0063 · Cited by 83
Inhibition of the Canonical IKK/NFκB Pathway Sensitizes Human Cancer Cells to Doxorubicin
Tapia-Laliena, M. Á., González-Navarrete, I., Dalmases, A., Bosch, M., Rodríguez‐Fanjul, V., Rolfe, M., Ross, J. S., Mezquita, J., Mezquita, C., Bachs, O., et al. (2007) · Cell Cycle · doi:10.4161/cc.6.18.4721 · Cited by 75
Tew, G. W., Lorimer, E., Berg, T. J., Zhi, H., Li, R., & Williams, C. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707526200 · Cited by 60
Targeting NF‐κB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth
Jourdan, M., Moreaux, J., Vos, J. D., Hose, D., Mahtouk, K., Abouladzé, M., Robert, N., Baudard, M., Reme, T. X., Romanelli, A., et al. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06629.x · Cited by 56
Systemic Targeting Inhibitor of κB Kinase Inhibits Melanoma Tumor Growth
Yang, J., Pan, W.-H., Clawson, G. A., & Richmond, A. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3547 · Cited by 54
Carvalho, G., Fabre, C., Braun, T., Grosjean, J., Adès, L., Agou, F., Tasdemir, E., Boehrer, S., Israël, A., Véron, M., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1210043 · Cited by 50
Rae, C. J., Langa, S., Tucker, S. J., & MacEwan, D. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701437104 · Cited by 42
Chen, H., Li, M., Campbell, R. A., Burkhardt, K., Zhu, D., Li, S. G., Lee, H. J., Wang, C., Zeng, Z., Gordon, M. S., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209653 · Cited by 41
Izzo, J. G., Malhotra, U., Wu, T., Luthra, R., Correa, A. M., Swisher, S. G., Hofstetter, W. L., Chao, K. S. C., Hung, M., & Ajani, J. A. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-1083 · Cited by 27
NF-κB inhibition by an adenovirus expressed aptamer sensitizes TNFα-induced apoptosis
Mi, J., Zhang, X., Liu, Y., Reddy, S. K., Rabbani, Z. N., Sullenger, B. A., & Clary, B. M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.125 · Cited by 19
Cited by
Eltzschig, H. K., & Carmeliet, P. (2011) · New England Journal of Medicine · doi:10.1056/nejmra0910283 · Cited by 2,061
Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974
Self-citationTumor-associated macrophages (TAM) as major players of the cancer-related inflammation
Solinas, G., Germano, G., Mantovani, A., & Allavena, P. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0609385 · Cited by 1,425
Iliopoulos, D., Hirsch, H. A., & Struhl, K. (2009) · Cell · doi:10.1016/j.cell.2009.10.014 · Cited by 1,374
Inflammatory networks during cellular senescence: causes and consequences.
Freund, A., Orjalo, A. V., Desprez, P.-Y., & Campisi, J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.03.003 · Cited by 1,354
Metadata
- Authors
- Naugler, W. E., & Karin, M.
- Venue
- Current Opinion in Genetics & Development
- Publisher
- Elsevier BV
- Published
- 2008-02
- Volume
- 18
- Issue
- 1
- Pages
- 19-26
- ISSN
- 0959-437X (ISSN-L)
- OpenAlex
- W2039817035
- Cited by
- 636
- References
- 61
- FWCI
- 2.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.